Podophyllotoxin-d6
(Synonyms: PPT-d6) 目录号 : GC49077An internal standard for the quantification of podophyllotoxin and picropodophyllotoxin
Sample solution is provided at 25 µL, 10mM.
Podophyllotoxin-d6 is intended for use as an internal standard for the quantification of podophyllotoxin and picropodophyllotoxin by GC- or LC-MS. Podophyllotoxin is a lignan that has been found in Podophyllum and has diverse biological activities.1,2,3,4,5 It inhibits polymerization of isolated chicken brain tubulin (IC50 = 0.6 µM) and induces mitotic arrest at the G2/M phase in CCRF CEM lymphoblastic leukemia cells when used at concentrations ranging from 0.01 to 5 µg/ml.2,3 Podophyllotoxin (5 µM) is protective against herpes simplex virus 1 (HSV-1) infection in Vero cells.4 It inhibits the proliferation of several diffuse large B cell lymphoma (DLBCL) cell lines (IC50s = 0.0098-0.017 µM).5 Podophyllotoxin is a starting material in the semisynthesis of the anticancer compounds etoposide and teniposide .6 Formulations containing podophyllotoxin have been used in the treatment of external genital warts.
1.Imbert, T.F.Discovery of podophyllotoxinsBiochimie80(3)207-222(1998) 2.Loike, J.D., Brewer, C.F., Sternlicht, H., et al.Structure-activity study of the inhibition of microtubule assembly in vitro by podophyllotoxin and its congenersCancer Res.38(9)2688-2693(1978) 3.Krishan, A., Paika, K., and Frei, E., IIICytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblastsJ. Cell Biol.66(3)521-530(1975) 4.Hammonds, T.R., Denyer, S.P., Jackson, D.E., et al.Studies to show that with podophyllotoxin the early replicative stages of herpes simplex virus type 1 depend upon functional cytoplasmic microtubulesJ. Med. Microbiol.45(3)167-172(1996) 5.StrÖmberg, T., Feng, X., Delforoush, M., et al.Picropodophyllin inhibits proliferation and survival of diffuse large B-cell lymphoma cellsMed. Oncol.32(7)188(2015) 6.Xu, H., Lv, M., and Tian, X.A review on hemisynthesis, biosynthesis, biological activities, mode of action, and structure-activity relationship of podophyllotoxins: 2003-2007Curr. Med. Chem.16(3)327-349(2009)
Cas No. | N/A | SDF | |
别名 | PPT-d6 | ||
Canonical SMILES | O=C1[C@]2([H])[C@@](C3=CC(OC([2H])([2H])[2H])=C(C(OC)=C3)OC([2H])([2H])[2H])([H])C4=CC(OCO5)=C5C=C4[C@@H]([C@@]2([H])CO1)O | ||
分子式 | C22H16D6O8 | 分子量 | 420.4 |
溶解度 | Acetonitrile: soluble,DMF: soluble,DMSO: soluble,Ethanol: soluble,Methanol: soluble | 储存条件 | -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.3787 mL | 11.8934 mL | 23.7869 mL |
5 mM | 0.4757 mL | 2.3787 mL | 4.7574 mL |
10 mM | 0.2379 mL | 1.1893 mL | 2.3787 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet